Evidence map›Paper›PMID 37476929›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Implementing Preexposure Prophylaxis for HIV Prevention in a Statewide Correctional System in the United States.

Matthew Murphy, Brooke G Rogers, Evan Ames, Drew Galipeau, Julia Uber, Siena Napoleon, Lauren Brinkley-Rubinstein, Emily Toma, Sophie Byrne, Anne M Teitelman and 3 more

Open access · greenAbstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. State-of-the-Art Review: The Intersection of Infectious Diseases and Carceral Medicine.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Matthew MurphyWarren Alpert School of Medicine, Brown University, Providence, RI, USA.
Brooke G RogersWarren Alpert School of Medicine, Brown University, Providence, RI, USA.
Evan AmesRhode Island Hospital, Providence, RI, USA.
Drew GalipeauThe Miriam Hospital, Providence, RI, USA.
Julia UberRhode Island Hospital, Providence, RI, USA.
Siena NapoleonBrown University School of Public Health, Providence, RI, USA.
Lauren Brinkley-RubinsteinDuke University, Durham, NC, USA.
Emily TomaBrown University School of Public Health, Providence, RI, USA.ORCID 0000-0002-9057-757X
Sophie ByrneRhode Island Hospital, Providence, RI, USA.
Anne M TeitelmanThe University of Pennsylvania, Philadelphia, PA, USA.
Justin BerkWarren Alpert School of Medicine, Brown University, Providence, RI, USA.
Philip A ChanWarren Alpert School of Medicine, Brown University, Providence, RI, USA.ORCID 0000-0003-0964-5895
Susan RamseyWarren Alpert School of Medicine, Brown University, Providence, RI, USA.
Providence College · USBrown University · USDuke University · USUniversity of Pennsylvania · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: A Pilot Randomized Controlled TrialK23DA055695 · NIDA · RHODE ISLAND HOSPITAL · PI Justin Berk · 2022 to 2026
$1.0M
An intervention to improve HIV pre-exposure prophylaxis initiation, adherence and linkage to care for recently incarcerated men who inject drugs.K23DA054003 · NIDA · RHODE ISLAND HOSPITAL · PI Matthew Murphy · 2022 to 2026
$977k
Linkage to Community-Based HIV Pre-Exposure Prophylaxsis Care Among at Risk Women upon Release from IncarcerationR34DA045621 · NIDA · RHODE ISLAND HOSPITAL · PI RAMSEY, SUSAN E · 2017 to 2019
$753k
NIAID NIH HHS P30 AI042853NIDA NIH HHS K23 DA054003NIDA NIH HHS K23 DA055695NIDA NIH HHS R34 DA045621
6 · The paper itself

Abstract

HIV disproportionately affects populations experiencing incarceration. Preexposure prophylaxis (PrEP) is an effective approach to preventing HIV acquisition among populations at increased risk of acquiring HIV. Yet few, if any, efforts have been made to offer PrEP in correctional settings. Beginning in November 2019, the Rhode Island Department of Corrections (RIDOC) implemented a systemwide PrEP initiation program with linkage to PrEP care in the community upon reentry. Incarcerated individuals identified as being potentially at increased risk of HIV acquisition during standard clinical screenings and medical care were referred to a PrEP care provider for potential PrEP initiation. Of the 309 people who met with a PrEP care provider, 35% (n = 109; 88 men, 21 women) agreed to initiate PrEP while incarcerated. Clinical testing and evaluation were completed for 82% (n = 89; 69 men, 20 women) of those who agreed to initiate PrEP. Of those, 54% (n = 48; 29 men, 19 women) completed the necessary clinical evaluation to initiate PrEP, were determined to be appropriate candidates for PrEP use, and had the medication delivered to a RIDOC facility for initiation. Only 8 people (4 men, 4 women) were successfully linked to a PrEP care provider in the community after release. The RIDOC experience demonstrates notable levels of PrEP interest and moderate levels of PrEP uptake among this population. However, PrEP engagement in care after release and persistence in taking PrEP when in the community were relatively poor, indicating a need to better understand approaches to overcoming barriers to PrEP care in this unique setting.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisPrisonersFemaleHomosexuality, MaleHumansMaleRhode IslandUnited StatesAnti-HIV AgentscorrectionsHIVPrEP

Identifiers

PMID37476929
PMCPMC10851896
OpenAlexW4384925644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.